Zhewitra Oral Jelly
Intended to relieve erectile dysfunction to support physical performance and target cavernous smooth muscle relaxation.
- Category
- Erectile Dysfunction
- Active ingredient
- Vardenafil
- Route
- Oral use
- Form
- Sachet
- Strengths
- 20mg
Prescription and consultation requirements for Zhewitra Oral Jelly vary by destination and are determined by the fulfilment partner.
Zhewitra Oral Jelly details
- Condition
- Erectile Dysfunction
- Alternative names
- vardenafil
- Therapeutic class
- Phosphodiesterase-5 Inhibitor
- Pharmacological class
- PDE5 Inhibitor
- Contraindications
- organic nitrates; severe cardiac disease; severe hepatic impairment
- Minor side effects
- headache; flushing; dyspepsia
- Moderate side effects
- nasal congestion; dizziness; minor visual blur
- Serious side effects
- priapism, requires immediate medical attention
- Dosage forms
- Sachet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Sunrise Remedies
- Onset Time
- 15–30 minutes
- Duration
- 4–5 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Nitrates; Alpha Blockers; Grapefruit
- Age restrictions
- Approved for adult men.
- Pregnancy and breastfeeding
- TGA Category B: Not intended for female use. Breastfeeding: Not applicable.
Patient summary
intended to relieve erectile dysfunction to support physical performance and target cavernous smooth muscle relaxation.
Mechanism of action
Absorbed rapidly as an oral gel, blocking local PDE5 enzymes to elevate cGMP levels and facilitate penile erection.